Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Amino Acids
|
January 1, 1999
Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects
G Fisher, N Lorenzo, H Abe, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid
S M Monte, K Ghanbari, W H Frey, et al.
Brain Research Bulletin
|
January 1, 1992
Racemized D-aspartate in Alzheimer neurofibrillary tangles
G H Fisher, I L Payan, S J Chou, et al.
Journal of Neurochemistry
|
February 1, 1987
D-aspartate in human brain
E H Man, G H Fisher, I L Payan, et al.
Molecular and Chemical Neuropathology
|
October 1, 1994
Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects
G H Fisher, L Petrucelli, C Gardner, et al.
Human Molecular Genetics
|
September 1, 1992
Deletion in the prion protein gene in a demented patient
J F Diedrich, D S Knopman, J F List, et al.
Brain Research
|
April 1, 1996
Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor
W H Frey, M M Najarian, K S Kumar, et al.
Brain Research
|
August 1, 1997
Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation
H D Venters, L E Bonilla, T Jensen, et al.
Neuroscience
|
October 28, 2008
Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis
J A Martinez, G J Francis, W Q Liu, et al.
Brain Research
|
June 15, 2014
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease
J M Fine, A C Forsberg, D B Renner, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Amino Acids
|
January 1, 1999
Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects
G Fisher, N Lorenzo, H Abe, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid
S M Monte, K Ghanbari, W H Frey, et al.
Brain Research Bulletin
|
January 1, 1992
Racemized D-aspartate in Alzheimer neurofibrillary tangles
G H Fisher, I L Payan, S J Chou, et al.
Journal of Neurochemistry
|
February 1, 1987
D-aspartate in human brain
E H Man, G H Fisher, I L Payan, et al.
Molecular and Chemical Neuropathology
|
October 1, 1994
Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects
G H Fisher, L Petrucelli, C Gardner, et al.
Human Molecular Genetics
|
September 1, 1992
Deletion in the prion protein gene in a demented patient
J F Diedrich, D S Knopman, J F List, et al.
Brain Research
|
April 1, 1996
Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor
W H Frey, M M Najarian, K S Kumar, et al.
Brain Research
|
August 1, 1997
Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation
H D Venters, L E Bonilla, T Jensen, et al.
Neuroscience
|
October 28, 2008
Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis
J A Martinez, G J Francis, W Q Liu, et al.
Brain Research
|
June 15, 2014
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease
J M Fine, A C Forsberg, D B Renner, et al.
Page
of 9